Tempest Therapeutics, Inc.
USD1.08
-0.02 (-1.82%)
CEO
Matthew Angel
IPO Date
2012-11-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.10
Prev. Close
$1.10
Day Low
$1.08
Day High
$1.12
52W Low
$1.02
52W High
$12.23
Market Cap
$0.00B
Volume
0.05M
| -7.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -110.2% | -57.1% | 0.77 | 4.29 | -29.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -197.2% | -77.5% | 1.22 | 4.53 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -78.4% | -38.6% | 0.51 | 3.44 | -0.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 27.8% | -83.6% | -0.04 | 6.15 | -0.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -76.1% | -59.4% | 0.08 | 5.68 | -26.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -38.3% | -32.3% | 0.01 | 8.50 | -5.9 |
| 31 Dec 2017 | FY | 90.5% | -28670.5% | -3796.1% | -426.9% | 0.35 | 4.82 | -0.1 |
| 31 Dec 2016 | FY | -727.1% | -12597.2% | -76.0% | -67.1% | 0.00 | 8.82 | -7.8 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -55.3% | -20.5% | 1.32 | 2.30 | -3.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -80.4% | -32.1% | 0.89 | 2.11 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -97.5% | -33.8% | 1.18 | 1.70 | -0.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -72.2% | -33.3% | 0.80 | 2.21 | -5.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -92.1% | -31.2% | 1.55 | 1.69 | -11.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -56.5% | -22.7% | 1.20 | 2.17 | -16.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -38.3% | -17.8% | 0.99 | 3.13 | -49.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -28.0% | -14.5% | 0.77 | 4.29 | -41.1 |